Mirum Pharmaceuticals
As of November 20, 2026, Mozibox lists 3 physician openings at Mirum Pharmaceuticals, all nonclinical, in 2 metro areas; 1 posts an annual base salary, too few to summarize. In the past 12 months Mirum Pharmaceuticals posted 18 nonclinical physician roles, the most recent on September 30, 2026, in medical affairs, MSL, clinical development, and 2 other functions.
About Mirum Pharmaceuticals
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat), CHOLBAM® (cholic acid) capsules, and CTEXLI™ (chenodiol) tablets. LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients 12 months of age and older; in Europe, it is approved for patients with PFIC three months of age and older. Mirum is also initiating the Phase 3 EXPAND study, a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms of liver disease. CTEXLI is FDA-approved for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Mirum's late-stage pipeline includes two investigational treatments for several rare diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2 VISTAS study for primary sclerosing cholangitis (PSC) and Phase 2b VANTAGE study for primary biliary cholangitis (PBC). Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Mirum is also planning for a Phase 2 study evaluating MRM-3379, a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder.
Where They Are Hiring
- Boston, MA 1 openings
- San Francisco, CA 1 openings
- Outside a metro area 1 openings
Posted Pay
Not enough postings list pay: 1 of 3 openings post an annual base salary.
Nonclinical Roles
In the past 12 months, Mirum Pharmaceuticals posted 18 nonclinical physician roles; 3 are open now. 10 posted an annual base salary: median $236,000, middle half $218,000 to $298,000. Nonclinical physician jobs at every company Companies with nonclinical physician roles
- Medical Affairs Strategy & Leadership 5 roles
- Medical Science Liaison (MSL) 5 roles
- Clinical Development & Trial Design 4 roles
- Medical Communications & Strategic Planning 2 roles
- Pharmacovigilance & Drug Safety 2 roles
Newest Openings
Past Nonclinical Roles
-
Senior Vice President, Drug Safety and Pharmacovigilance
-
Medical Science Liaison, Florida
-
Associate Director, Global Medical Communications
-
Director, Scientific Affairs
-
Director, Clinical Development
-
Medical Science Liaison, Southeast
-
Executive Director, Clinical Development - GI/Hep/Liver
-
Executive Director, Clinical Development
-
Associate Director, Medical Safety Science
-
Senior Director, Global Medical Affairs Lead - LIV/BAP
-
Senior Director, Global Medical Affairs Lead - VLX
-
Field Medical Science Liaison Regional Director
-
Senior Director, Global Medical Affairs Lead
-
Medical Science Liaison
-
Associate Director, Medical Communications
Questions
How many physician jobs does Mirum Pharmaceuticals have?
As of November 20, 2026, Mozibox lists 3 physician openings at Mirum Pharmaceuticals: 0 clinical and 3 nonclinical. Mirum Pharmaceuticals posted 18 nonclinical physician roles in the past 12 months, most recently "Medical Science Liaison, New England" on September 30, 2026.
Where is Mirum Pharmaceuticals hiring physicians?
As of November 20, 2026, the most openings are in Boston, MA (1) and San Francisco, CA (1) and 1 opening is outside the named metro areas.
How much does Mirum Pharmaceuticals pay physicians?
The median annual base salary Mirum Pharmaceuticals posted for 10 nonclinical physician roles in the past 12 months was $236,000; the middle half ran from $218,000 to $298,000. These are figures the employer posted, not estimates.
What nonclinical roles does Mirum Pharmaceuticals hire physicians for?
In the past 12 months Mirum Pharmaceuticals posted 18 nonclinical physician roles: medical affairs (5), MSL (5), clinical development (4), and medical communications (2).
How We Count
- What counts. Active physician postings on Mozibox, clinical and nonclinical, onsite, hybrid, field and remote. Counts are refreshed hourly and dated with the latest count.
- Company profile. The industry, size, headquarters, links and About text come from the company's LinkedIn profile. Key contacts are physician leaders at the company with public profiles.
- Employer. The employer of record each posting names, matched to its company by name, LinkedIn name or a known alternative name. A health system's hospitals and medical groups that post under their own names have their own pages.
- Openings. Postings for the same role at the same employer in the same place count once: the same metro area, else the same city, or both remote.
- Specialty. A clinical opening belongs to the one specialty it is for: the specialty its title names, else the specialty its requirements name. Openings open to several unrelated specialties, and roles such as urgent care or wound care, count as other clinical openings. Metro links next to a specialty, and specialty links next to a metro, go to that specialty's page for the metro, which lists these openings among other employers'.
- Metro area. Each metro area is a Census metropolitan statistical area. An onsite opening belongs to the one containing its primary location.
- Pay. Annual base salary as the employer posted it, in US dollars. Hourly pay is not converted, maximum-only figures ("up to") are left out, and figures outside $100,000-$1,500,000 or ranges whose top is more than 3 times the bottom are treated as placeholders. Each opening counts by the middle of its range. A median and middle half are shown only from 8 or more openings. These are posted figures, not estimates.
- What the openings are. Counts of openings by care setting, employment type and work mode; some postings state no care setting or employment type.
- Past nonclinical roles. Nonclinical physician roles the company posted in the past 12 months, open now or since closed, including postings that had already closed when Mozibox found them. Reposts of the same title in the same place count once. The dates are the dates the roles were posted, and titles, places and pay are as posted.
- Which pages exist. A company gets a page once it has at least 10 openings, or posted at least 10 nonclinical physician roles in the past 12 months, and its company record passes Mozibox's identity checks. Mozibox lists the jobs it collects, not every vacancy a company has.